G7 Freedom Constrained Vivacit-E Liners

NAEnrolling by invitationINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

December 31, 2037

Study Completion Date

December 31, 2038

Conditions
Osteoarthritis, HipRheumatoid ArthritisNon-Union FractureTrochanteric FracturesFemoral Neck FracturesAvascular NecrosisDislocation, Hip
Interventions
DEVICE

Total Hip Arthroplasty with G7 Freedom Constrained Vivacit-E Liners

Primary and/or Revision total hip arthroplasty with the G7 Freedom Constrained Vivacit-E Liners

Trial Locations (10)

26506

West Virginia University, Morgantown

32611

University of Florida Board of Trustees, Gainesville

35205

University of Alabama at Birmingham, Birmingham

37923

TOA Research Foundation, Knoxville

43201

The Ohio State University, Columbus

75075

Medical City Plano, Plano

77030

The University of Texas Health Science Center of Houston, Houston

84108

University of Utah, Salt Lake City

90033

University of Southern California, Los Angeles

07039

Jersey City Medical Center, Inc, Livingston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT05587244 - G7 Freedom Constrained Vivacit-E Liners | Biotech Hunter | Biotech Hunter